drugset / Trial / NCT02071810
Tolerability, Pharmacokinetics and Pharmacodynamics of BIA 9-1067
RandomizedParallel-groupTriple-blindTreatment
Summary
The purpose of this study is to assess the tolerability of BIA 9-1067 after multiple rising dose regimens of BIA 9-1067.
Timeline
- Start
- 2008-04
- Primary completion
- 2008-09
- Completion
- 2008-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Opicapone | Small molecule | 5 mg | — |
| Subject | Opicapone | Small molecule | 10 mg | — |
| Subject | Opicapone | Small molecule | 20 mg | — |
| Subject | Opicapone | Small molecule | 30 mg | — |